We detected a higher gene expression of CD6 and ALCAM and fms-related tyrosine kinase 3 FLT3 ligand, and SH2D1A encoded signalling lymphocyte activation molecule (SLAMF1) in PBMCs of patients with early and established RA [Fig. 1f]. The gene discussed is FLT3; the disease is rheumatoid arthritis.